Search clinical trials for: Empagliflozin (Jardiance®;
Total 14620 results
-
Dong-A ST Co., Ltd.CompletedType2 DiabetesKorea, Republic of
-
Handok Inc.CompletedType 2 Diabetes MellitusKorea, Republic of
-
October 6 UniversityUniversity of Florida; Beni-Suef University; National Heart Institute, EgyptRecruitingHeart Failure | Genetic PolymorphismsUnited States
-
Centro Universitario de Ciencias de la Salud, MexicoActive, not recruitingDiabetes Mellitus Type 2 Without ComplicationMexico
-
Clinical Research Centre, MalaysiaUniversity of Malaya; Ministry of Health, MalaysiaRecruitingCoronary Artery DiseaseMalaysia
-
Damanhour UniversityRecruitingHeart Failure | Reduced Ejection Fraction Heart FailureEgypt
-
Centro Universitario de Ciencias de la Salud, MexicoUnknownType 2 Diabetes MellitusMexico
-
Boehringer IngelheimEli Lilly and CompanyActive, not recruiting
-
Medical University of WarsawMedical University of Graz; Medical University of Vienna; Poznan University of... and other collaboratorsRecruitingAcute Decompensated Heart FailurePoland
-
Boehringer IngelheimEli Lilly and CompanyCompletedHeart FailureUnited States, Spain, Canada, Korea, Republic of, China, Germany, Belgium, Australia, Italy, United Kingdom, Argentina, Hungary, Czechia, Poland, Netherlands, Japan, Mexico, India, Brazil, France
-
Boehringer IngelheimEli Lilly and CompanyCompletedHeart FailureUnited States, Spain, Canada, Germany, Greece, Australia, Sweden, Italy, Norway, Poland, Portugal
-
Boehringer IngelheimRecruitingHeart FailureKorea, Republic of
-
Boehringer IngelheimEli Lilly and CompanyCompletedHeart FailureUnited States, Spain, Korea, Republic of, China, Germany, Belgium, Australia, Singapore, Canada, Italy, Argentina, Hungary, Czechia, Poland, Netherlands, Japan, United Kingdom, Mexico, Romania, Brazil, India, South Africa, Colombia
-
University of PennsylvaniaRecruitingHeart Failure With Preserved Ejection FractionUnited States
-
University Hospital TuebingenWithdrawn
-
Pharma NuevaNot yet recruiting
-
Boehringer IngelheimEli Lilly and CompanyCompletedHeart FailureUnited Kingdom
-
Boehringer IngelheimEli Lilly and CompanyCompletedHeart FailureUnited States, Spain, Canada, Germany, Australia, Greece, Italy, Norway, Poland, Portugal, Sweden
-
China National Center for Cardiovascular DiseasesRecruitingHypertension | Pre-Heart FailureChina
-
Ministry of Health and Population, EgyptCompleted
-
University Hospital, Basel, SwitzerlandBoehringer IngelheimRecruitingPostprandial HypoglycemiaSwitzerland
-
LG ChemUnknown
-
University of PisaUnknownType 2 Diabetes | Urinary Tract InfectionsItaly
-
National Taiwan University HospitalShin Kong Wu Ho-Su Memorial HospitalNot yet recruitingHeart Failure With Reduced Ejection Fraction | End Stage Renal Disease on Dialysis
-
Ain Shams UniversityDrug Research Centre, Cairo, EgyptCompletedDiabetes Mellitus | Pharmacokinetics | PharmacodynamicsEgypt
-
Boehringer IngelheimRecruitingKidney Disease, ChronicKorea, Republic of
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Japan
-
Instituto Nacional de Cardiologia Ignacio ChavezNot yet recruitingSTEMI | No-Reflow Phenomenon
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Korea, Republic of
-
Boehringer IngelheimActive, not recruitingHeart FailureCzechia, Switzerland, Poland, Hungary, Romania, Bulgaria
-
Boehringer IngelheimCompleted
-
The University of Texas Health Science Center at...National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Doris...RecruitingType2 Diabetes | Heart Failure With Preserved Ejection FractionUnited States
-
Seoul National University Bundang HospitalNot yet recruitingType 2 Diabetes | Metabolic-associated Fatty Liver Disease
-
University of Mississippi Medical CenterEli Lilly and CompanyRecruiting
-
Anita SarafThe Pittsburgh FoundationNot yet recruitingHeart Failure | Adult Congenital Heart DiseaseUnited States
-
Ain Shams UniversityCompletedPharmacokinetics | PharmacogenomicEgypt
-
National Institute on Aging (NIA)CompletedPhysiological Effects of Drugs | Hypoglycemic Agents | Empaglifozin | Sodium-Glucose Transporter 2 InhibitorsUnited States
-
Mario Negri Institute for Pharmacological ResearchBoehringer IngelheimWithdrawnObesity | Non-diabetic Chronic Kidney Disease
-
The University of Texas Health Science Center at...National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Recruiting
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Japan
-
University Health Network, TorontoNot yet recruitingEnd Stage Kidney Disease | Kidney Dysfunction | Peritoneal Dialysis Complication | Sodium-glucose Co-transporter-2 Inhibitors | Residual Kidney FunctionCanada
-
Medical University of ViennaCompletedPosttransplant Diabetes MellitusAustria
-
The Deutsche Diabetes Forschungsgesellschaft e.V.Novo Nordisk A/S; Boehringer Ingelheim; Federal Ministry of Health, Germany; German... and other collaboratorsRecruitingType 2 Diabetes | Non-alcoholic Fatty Liver Disease (NAFLD) | Non-alcoholic Steatohepatitis (NASH)Germany, Austria
-
Vanderbilt University Medical CenterRecruitingObesity | Metabolic SyndromeUnited States
-
NYU Langone HealthNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Boehringer...Recruiting
-
Washington University School of MedicineRecruitingEpilepsyUnited States
-
University of UtahNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingHemodialysis | Kidney Disease, Chronic | Kidney Failure | Dialysis | Diabetic | End-stage Kidney Disease | Kidney Dysfunction | Non-diabeticUnited States
-
Maria Sklodowska-Curie National Research Institute...Medical Research Agency, PolandRecruiting
-
National Institute of Cardiology, Warsaw, PolandAmsterdam UMC, location VUmc; University of Eastern Finland; Medical University...RecruitingHeart Failure | Hypertrophic CardiomyopathyPoland